PharmaLundensis AB
PHAL
PHAL
Insider Trading Activity
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | 2026-06-04 | S Sale |
Chief Executive Officer (CEO)/Managing Directory Officer |
20,907
344.78
SEK296,516 |
20,907 | 344.78 | SEK296,516 | |
| 2026-02-24 | 2026-02-20 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
97,761
272.28
SEK2,318,244 |
97,761 | 272.28 | SEK2,318,244 | |
| 2025-10-04 | 2025-10-01 | S Sale |
Chief Executive Officer (CEO)/Managing Directory Officer |
53,803
144.45
SEK172,602 |
53,803 | 144.45 | SEK172,602 | |
| 2025-09-25 | 2025-09-24 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
92,333
0.19
SEK17,543 |
92,333 | 0.19 | SEK17,543 | |
| 2025-09-25 | 2025-09-24 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
63,017
0.22
SEK13,864 |
63,017 | 0.22 | SEK13,864 | |
| 2025-09-25 | 2025-09-23 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
65,656
0.20
SEK13,131 |
65,656 | 0.20 | SEK13,131 | |
| 2025-03-12 | 2025-03-11 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
2,337
0.85
SEK1,986 |
2,337 | 0.85 | SEK1,986 | |
| 2025-03-10 | 2025-03-06 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
3,713
0.85
SEK3,156 |
3,713 | 0.85 | SEK3,156 | |
| 2025-03-10 | 2025-02-27 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
200,000
1.00
SEK200,000 |
200,000 | 1.00 | SEK200,000 | |
| 2025-01-21 | 2025-01-17 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
121,700
0.79
SEK96,143 |
121,700 | 0.79 | SEK96,143 | |
| 2025-01-21 | 2025-01-17 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
10,958
0.73
SEK7,999 |
10,958 | 0.73 | SEK7,999 | |
| 2024-10-16 | 2024-10-14 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
49,370
0.40
SEK19,748 |
49,370 | 0.40 | SEK19,748 | |
| 2024-10-13 | 2024-10-09 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
27,936
0.37
SEK10,336 |
27,936 | 0.37 | SEK10,336 | |
| 2024-09-30 | 2024-09-26 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
63,000
0.47
SEK29,610 |
63,000 | 0.47 | SEK29,610 | |
| 2024-09-25 | 2024-09-25 | B Purchase |
Chairman of the Board of Directors Director |
800,000
0.50
SEK400,000 |
800,000 | 0.50 | SEK400,000 | |
| 2024-09-24 | 2024-09-23 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
200,000
0.50
SEK100,000 |
200,000 | 0.50 | SEK100,000 | |
| 2024-09-27 | 2024-09-20 | B Purchase |
Member of the Board of Directors Director |
60,000
0.46
SEK27,600 |
60,000 | 0.46 | SEK27,600 | |
| 2024-09-21 | 2024-09-20 | B Purchase |
Member of the Board of Directors Director |
60,000
0.46
SEK27,600 |
60,000 | 0.46 | SEK27,600 | |
| 2024-09-19 | 2024-09-17 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
3,999,999
0.50
SEK2,000,000 |
3,999,999 | 0.50 | SEK2,000,000 | |
| 2024-09-15 | 2024-09-13 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
50,668
0.45
SEK22,801 |
50,668 | 0.45 | SEK22,801 |
More insider trading research around PharmaLundensis AB
